Patent · US Expired

Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies

US6692741B2 · kind B2 · utility

12Cited by
5References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2001
Grant dateFeb 17, 2004
Priority date—
Expiry dateJun 1, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions comprising antagonists of &agr;v&bgr;6 are provided for the treatment of acute lung injury fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.